Dr. Shiwei Duan

Address:

Hangzhou City University, Zhejiang, China

Research Interests:

• Epigenomics / DNA methylation / Noncoding RNAs
• Pharmacogenomics in cancer therapy
• Genetic variation and gene expression (eQTLs)
• Complex disease genomics
• Biomarker discovery & translational epigenetics
• Stem cell genomics and mitochondrial profiling​

Biography:

Dr. Shiwei Duan is a leading researcher in epigenetics and epigenomics, currently serving as Professor of Medicine at Hangzhou City University. She earned her PhD in Molecular Cell Biology from Shanghai Jiao Tong University in 2005 and has held research appointments in internationally respected institutions. Duan’s research spans a broad array of topics including DNA/RNA methylation, noncoding RNAs, genetic variation, and their roles in chemotherapy response, cancer, and complex human diseases. According to Google Scholar, she has over 11,000 citations, an h-index above 50, and a robust i10-index, demonstrating sustained academic influence. Her work includes both fundamental discoveries (e.g., linking SNPs to gene expression, evaluation of variation across populations) and more translational studies addressing biomarkers, therapeutic targets, and molecular mechanisms of disease. Dr. Duan is actively publishing and collaborating, and her expertise in epigenomics is widely recognized in cancer research, pharmacogenomics, and complex disease genomics. She also supervises postgraduate work, contributes to peer review, and participates in academic leadership in molecular pathology and genomics.

Education Details

• PhD, Molecular Cell Biology – Shanghai Jia Tong University, 2005 
• MS (Applied Biochemistry) – East China University of Science and Technology, ~2002
• BS (Biochemistry) – East China University of Science and Technology, ~1997

 

Professional Background

• Professor, School of Medicine, Hangzhou City University, Zhejiang, China
• Editor / Researcher in epigenetics, cancer genomics, pharmacogenomics
• Collaborated internationally; work includes genetic association, miRNA, methylation, noncoding RNA function in disease contexts

 

Current Research Projects

• Exploring epigenetic biomarkers (DNA methylation, noncoding RNAs) in cancer and complex diseases
• Genetic / transcriptomic variation studies, population genetics relating to disease susceptibility and therapeutic response 
• Mitochondrial mutation profiling in stem cells — example: “Exploring haematopoietic stem cell dynamics…” (2024)